A comparative database for heart disease management

Benchmark 2 addresses the need for evidence-based therapy as it
relates to the treatment of patients with diseases affecting the heart.
Benchmark 2 was designed to provide our customers with a web-based
tool that allows them to compare outcomes in their patient populations
who are eligible and/or receiving IAB therapy.

For the first time, not just data, but comparative outcomes are well
within your grasp. You can easily make statistically significant
comparisons to thousands of IABP cases, or simply identify and
track your own hospital data.

Features

• Patient profiles and demographics
• Clinical practice information such as indications for use, duration
  of therapy,catheter size and insertion techniques used, as well as
  concomitant therapies
• Clinical outcomes including length of stay, complications and
  mortality, with and without IABP

Benefits

• Clinical pathway improvement
• Improve quality of practice
• Optimize outcomes
• Create individualized study

Only participating Datascope customers have access to the
Benchmark 2™ Counterpulsation Study database – currently
about 80% of the institutions administering IABP therapy worldwide.

To Register:

Call us today at 800.777.4222, ext. 6100 (US only).
Outside of the US call 973.244.6100.
Or Contact Us through your local Datascope office.

Sales Literature